Controlled release interferon drug products and treatment of HCV infection using same

Details for Australian Patent Application No. 2008279087 (hide)

Owner Biolex Therapeutics, Inc.

Inventors Verrijk, Rudolf; Spencer Jr, David Gelvin; Humphries, John Elliot; De Leede, Leonardus Gerardus Jozef

Agent Watermark

Pub. Number AU-A-2008279087

PCT Pub. Number WO2009/015336

Priority 60/952,140 26.07.07 US; 60/951,879 25.07.07 US; 60/985,526 05.11.07 US; 60/978,330 08.10.07 US

Filing date 25 July 2008

Wipo publication date 29 January 2009

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/74 (2006.01) - Synthetic polymeric materials

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/015336 Priority application(s): WO2009/015336

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008279091-Treatment of post-traumatic stress disorder

2008279084-Dry fractionation of corn